Clinical trial
Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
NCT05124184 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 24, 2022
- Completion date
- July 22, 2024
- Enrollment
- 356 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
aaa - abdominal aortic aneurysm, end-stage renal disease, pad - peripheral arterial disease